SequenceME genetic study - from Oxford Nanopore Technologies, the University of Edinburgh and Action for ME

Is there a description of the population to be used as a comparison for the SV data generated by SequenceME from ME/CFS patients? I think the reference population may be the one described here, which includes 189 subjects of European ancestry genotyped by Oxford Nanopore.

Same question for the methylation data.

This question may already have been answered elsewhere.
 
Last edited:
paolo said:
Is there a description of the population to be used as a comparison for the SV data generated by SequenceME from ME/CFS patients? I think the reference population may be the one described here, which includes 189 subjects of European ancestry genotyped by Oxford Nanopore.

Same question for the methylation data.

This question may already have been answered elsewhere.
Click to expand...

Oxford Nanopore is currently sequencing 50k UK Biobank participants, with completion by the end of 2026 (R). So this is probably the answer to my question.
 
You must log in or register to reply here.
Back
Top Bottom